Advertisement
News
Advertisement

Amgen Oncology Data to be Presented at ASCO Annual Meeting

Wed, 05/18/2011 - 3:22pm
Amgen

THOUSAND OAKS, Calif., May 18, 2011 /PRNewswire via COMTEX/—Amgen (NASDAQ: AMGN) today announced that data from studies involving nine Amgen products will be presented at the 2011 American Society of Clinical Oncology (ASCO) Annual Meeting, June 3 - 7, 2011 in Chicago. These studies include data from the XGEVA® (denosumab), Vectibix® (panitumumab), ganitumab (AMG 479) and AMG 386 programs.

Read the rest of this entry

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading